Login/Sign Up
MRP ₹79.3
(Inclusive of all Taxes)
₹11.9 Cashback (15%)
Otsuka NS Flexidrip 0.9% Injection is used for fluid replacement. It contains Sodium chloride, which helps maintain the balance of fluid in and around the body’s cells and tissues. It aids in restoring the normal salt balance. It serves as a source of electrolytes and water, providing hydration. Sometimes, Otsuka NS Flexidrip 0.9% Injection may cause injection site reactions such as irritation, swelling, tenderness, and redness.
Provide Delivery Location
About Otsuka NS Flexidrip 0.9% Injection
Otsuka NS Flexidrip 0.9% Injection is indicated for the replacement of extracellular fluid, parenteral replenishment of fluid and sodium chloride as required by the patient’s clinical condition, and treatment of metabolic acidosis in the presence of fluid loss.
Otsuka NS Flexidrip 0.9% Injection contains Sodium chloride, which helps maintain the balance of fluid in and around the body’s cells and tissues. It aids in restoring the normal salt balance.
In some cases, Otsuka NS Flexidrip 0.9% Injection may cause injection site reactions, including irritation, swelling, tenderness, and redness. Most of these side effects do not require medical attention and will resolve gradually over time. However, talk to your doctor if the side effects persist or worsen.
Tell your doctor if you are allergic to any components in Otsuka NS Flexidrip 0.9% Injection. Consult your doctor if you are pregnant or breastfeeding. Keep your doctor informed about your health condition and any medications you are taking. Please consult your doctor if you have any concerns about using Otsuka NS Flexidrip 0.9% Injection in children.
Uses of Otsuka NS Flexidrip 0.9% Injection
Otsuka NS Flexidrip 0.9% Injection is used in the treatment of Fluid replacement. The detailed uses of Otsuka NS Flexidrip 0.9% Injection are as follows:
Have a query?
Directions for Use
Medicinal Benefits
How Otsuka NS Flexidrip 0.9% Injection Works
Storage
What if I have taken an overdose of Otsuka NS Flexidrip 0.9% Injection
Drug Warnings
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
by Others
by Others
by ABBOTT
by Others
by AYUR
Alcohol
Consult your doctor
It is unknown if alcohol interacts with Otsuka NS Flexidrip 0.9% Injection. Please consult your doctor if you have any concerns.
Pregnancy
Consult your doctor
If you are pregnant or planning pregnancy, inform your doctor before receiving Otsuka NS Flexidrip 0.9% Injection.
Breast Feeding
Consult your doctor
If you are breastfeeding, inform your doctor before receiving Otsuka NS Flexidrip 0.9% Injection.
Driving
Safe if prescribed
Otsuka NS Flexidrip 0.9% Injection is unlikely to affect your ability to drive.
Liver
Consult your doctor
If you have a history of liver disease, inform your doctor before receiving Otsuka NS Flexidrip 0.9% Injection.
Kidney
Caution
If you have a history of kidney disease, inform your doctor before receiving Otsuka NS Flexidrip 0.9% Injection. Otsuka NS Flexidrip 0.9% Injection should be used with caution in patients with renal insufficiency.
Children
Consult your doctor
Please consult your doctor. Your doctor may prescribe Otsuka NS Flexidrip 0.9% Injection as required based on the condition of your child.
Otsuka NS Flexidrip 0.9% Injection is indicated for the extracellular fluid replacement, parenteral replenishment of fluid and sodium chloride as required by the patient’s clinical condition, and treatment of metabolic acidosis in the presence of fluid loss. It helps prevent and treat salt and fluid imbalances in the body.
Otsuka NS Flexidrip 0.9% Injection helps maintain the balance of fluid in and around the body's cells and tissues. It aids in the restoration of the normal salt balance. Otsuka NS Flexidrip 0.9% Injection acts as a source of electrolytes and water for hydration.
Caution is advised if you are taking corticosteroids or corticotropin. Please consult your doctor.
Otsuka NS Flexidrip 0.9% Injection may cause hyponatremia (low level of sodium). The risk for hyponatremia is increased in elderly, paediatric patients, postoperative patients, and patients taking drugs which may increase the risk of hyponatremia. Close clinical monitoring in such patients is advised.
Country of origin
We provide you with authentic, trustworthy and relevant information